SOD1 and hyperthyroidism: These findings are supported by our previous evidence of higher SOD levels in liver tissue from rats receiving a daily injection of T2 for one week compared to control rats [56], as well as those of Guerra et al. [57], who found that patients with hyperthyroidism exhibited increased malondialdehyde (MDA) content and SOD activity compared to the control group.